Physician profile

Robert Jay Widmer

Interventional Cardiology · Temple, TX

NPI 1730319252

$140,057.52

in general payments reported to CMS, 2019-2025

33 companies · $25K in 2025

The $25K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$55,336.25
Food and Beverage$10,788.23
Travel and Lodging$10,200.31
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,337.68
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$3,500.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $58,369.10 2019-2025 Coroflow, Pressurewire, Optis
Medtronic, INC. $32,698.62 2021-2025 Symplicity G3, Resolute Onyx, Corevalve Evolut R
Philips North America LLC $29,415.12 2021-2025 (9520) Igt Devices Undivided, Igt Devices Undivided, Coronary Undivided
Pfizer INC. $7,704.69 2019-2022
Zoll Circulation INC $3,595.59 2021-2025 Catheter, Therox Ds2 Console, Downstream Cartridge
Edwards Lifesciences Corporation $2,756.72 2019-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia
Boston Scientific Corporation $1,274.96 2019-2024 Rotapro, Sentinel, Comet
Shockwave Medical, INC $993.53 2020-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary
Medtronic Vascular, INC. $445.06 2019-2020
Heartflow, INC. $439.92 2020-2021
Abiomed $312.71 2019-2025 Impella
Amgen INC. $304.70 2020-2025 Repatha, Repatha
W. L. Gore & Associates, INC. $275.85 2021-2024 Gore Cardioform Septal Occluder
E.R. Squibb & Sons, L.L.C. $267.96 2020-2025 Camzyos
Opsens INC. $168.95 2019
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Alnylam Pharmaceuticals INC. $166.59 2022-2025 Amvuttra
Penumbra, INC. $163.96 2025 Penumbra System
Cordis US Corp. $120.08 2024 Selution Slrpta
Acist Medical Systems, INC. $103.87 2025
Novo Nordisk INC $67.93 2020-2024 Ozempic, Rybelsus
Merck Sharp & Dohme LLC $60.67 2019
Terumo Medical Corporation $59.01 2021-2022
Teleflex LLC $56.88 2022-2024 Bandit, Trapliner, Guideliner
Spectrawave, INC $41.20 2025 Starlight Imaging Catheter, Hypervue Imaging System
Ge Healthcare $33.98 2025
Angiodynamics, INC. $33.60 2025 Auryon Laser System 100-120 Vac
Biosense Webster, INC. $30.08 2025 Nuvision Ice Catheter
Cathworks, INC. $28.54 2024 Ffrangio
Boehringer Ingelheim Pharmaceuticals, INC. $27.93 2023 Jardiance
Siemens Medical Solutions USA, INC. $23.81 2022
Cardiva Medical, INC. $15.91 2024 Savvywire

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Jay Widmer

$140,057.52

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $25K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/305778/robert-jay-widmer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.